{"gene":"UCKL1","run_date":"2026-06-10T10:51:56","timeline":{"discoveries":[{"year":2006,"finding":"UCKL1 (URKL-1) was identified as a substrate of the E3 ubiquitin ligase NKLAM via yeast two-hybrid screening; NKLAM and UCKL1 interact in mammalian cells (confirmed by co-immunoprecipitation and confocal microscopy), and NKLAM-mediated ubiquitination of UCKL1 leads to decreased UCKL1 protein expression.","method":"Yeast two-hybrid, co-immunoprecipitation, confocal microscopy, ubiquitination assay","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP confirmed in both transfected cells and endogenous protein, plus functional ubiquitination assay, yeast two-hybrid identification; multiple orthogonal methods in a single focused study","pmids":["16709802"],"is_preprint":false},{"year":2009,"finding":"Downregulation of UCKL1 by siRNA in K562 erythroleukemia cells initiated apoptosis, slowed the cell cycle, reduced cell growth, and increased susceptibility to staurosporine-induced apoptosis and NK-mediated cytolysis, establishing a role for UCKL1 in tumor cell survival.","method":"RNA interference (siRNA), cell cycle analysis, apoptosis assays, NK cytolysis assay","journal":"Apoptosis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KD with defined cellular phenotype using multiple readouts (apoptosis, cell cycle, NK killing), single lab","pmids":["19653100"],"is_preprint":false},{"year":2016,"finding":"UCKL1 over-expression in tumor cells protects against NK-mediated killing, spontaneous and drug-induced apoptosis, and increases tumor cell proliferation; NF-κB activity is elevated in UCKL1-overexpressing cells, suggesting NF-κB as a downstream mechanism of UCKL1-mediated survival.","method":"Overexpression transfection, NK cytolysis assay, apoptosis assay, NF-κB reporter/activity assay, in vivo tumor model","journal":"International journal of immunology and immunotherapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function with multiple phenotypic readouts and in vivo validation, NF-κB activity measured, single lab","pmids":["32083188"],"is_preprint":false},{"year":2016,"finding":"UCKL1 expression level in glioblastoma-initiating cells correlates with sensitivity to the nucleoside analog EUrd; UCKL1 positively regulates UMP synthesis, and increased UCKL1 expression together with decreased NT5C3 expression underlies the cytotoxic effect of EUrd on temozolomide-resistant GBM-initiating cells.","method":"Chemical screening, siRNA knockdown, cell viability assays, gene expression analysis","journal":"Stem cells","confidence":"Low","confidence_rationale":"Tier 3 / Weak — pharmacological/expression correlation with partial mechanistic follow-up; enzyme activity in this context inferred, not directly measured","pmids":["27090194"],"is_preprint":false},{"year":2022,"finding":"Purified recombinant UCKL1 phosphorylates uridine and cytidine using ATP as phosphate donor in vitro, with catalytic efficiencies (kcat/KM) of 1.2×10⁴ s⁻¹M⁻¹ for uridine and 0.7×10⁴ s⁻¹M⁻¹ for cytidine, establishing UCKL1 as a bona fide pyrimidine kinase. siRNA-mediated knockdown of UCKL1 in vivo reduced primary tumor growth and metastasis.","method":"Protein purification, in vitro kinase assay (kinetic characterization), siRNA knockdown, in vivo xenograft model","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro enzymatic reconstitution with kinetic parameters, complemented by in vivo loss-of-function; single lab but multiple orthogonal methods","pmids":["35583288"],"is_preprint":false},{"year":2023,"finding":"UCKL1 represses ferroptosis in colorectal cancer cells through a non-canonical, kinase-activity-independent mechanism: UCKL1 stabilizes Nrf2 protein, which in turn promotes expression of SLC7A11 (a ferroptosis repressor). UCKL1 knockdown enhanced lipid peroxidation and sensitized cells to GPX4 inhibitors in vitro and in vivo.","method":"RNA interference, GSH/GSSG assay, NADP+ assay, ROS and lipid peroxidation assays, metabolomics, RNA sequencing, western blotting, rescue assays, xenograft mouse model","journal":"EBioMedicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal biochemical assays, rescue experiments, and in vivo validation establishing the UCKL1-Nrf2-SLC7A11 axis; single lab but comprehensive approach","pmids":["37343364"],"is_preprint":false},{"year":2025,"finding":"UCKL1 and UCK2 physically assemble into a protein complex that acts as a molecular scaffold (independent of enzymatic/metabolic function) and recruits the E3 ubiquitin ligase TRIM21 to ubiquitinate and degrade Smurf2, thereby sustaining Smad3 phosphorylation and amplifying TGF-β fibrogenic signaling in cardiac fibroblasts. Combined genetic silencing of UCK2 and UCKL1 reduced myofibroblast differentiation and preserved cardiac function in a murine MI model.","method":"Co-immunoprecipitation (complex formation), western blotting, siRNA knockdown, AAV-mediated in vivo knockdown, murine MI model, TGF-β signaling assays","journal":"Molecular biomedicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP for complex, in vivo functional validation, multiple mechanistic readouts; single lab, no structural/reconstitution validation of scaffold function","pmids":["41457201"],"is_preprint":false}],"current_model":"UCKL1 is a pyrimidine salvage pathway enzyme (uridine/cytidine kinase) that also functions as a molecular scaffold: it is ubiquitinated and degraded by the E3 ligase NKLAM, protects tumor cells from apoptosis and NK-mediated killing partly via NF-κB, represses ferroptosis through a UCKL1-Nrf2-SLC7A11 axis independent of its kinase activity, and forms a complex with UCK2 that recruits TRIM21 to degrade Smurf2 and sustain Smad3/TGF-β fibrogenic signaling in cardiac fibroblasts."},"narrative":{"mechanistic_narrative":"UCKL1 is a pyrimidine salvage enzyme that doubles as a pro-survival and pro-fibrotic molecular scaffold, coupling nucleotide metabolism to cell-fate signaling in tumor and fibroblast contexts [PMID:35583288, PMID:37343364]. As an enzyme, purified recombinant UCKL1 phosphorylates uridine and cytidine using ATP, establishing it as a bona fide uridine/cytidine kinase that drives UMP synthesis [PMID:35583288, PMID:27090194]. Independent of this catalytic activity, UCKL1 promotes tumor cell survival: its loss triggers apoptosis, slows the cell cycle, and sensitizes cells to staurosporine and NK-mediated cytolysis, while its overexpression confers resistance to killing and elevates NF-κB activity [PMID:19653100, PMID:32083188]. A non-canonical, kinase-independent axis explains part of this survival role, in which UCKL1 stabilizes Nrf2 to induce the ferroptosis repressor SLC7A11, so that UCKL1 loss enhances lipid peroxidation and sensitizes cells to GPX4 inhibitors [PMID:37343364]. UCKL1 also assembles with UCK2 into a scaffold that recruits the E3 ligase TRIM21 to ubiquitinate and degrade Smurf2, thereby sustaining Smad3 phosphorylation and amplifying TGF-β fibrogenic signaling in cardiac fibroblasts [PMID:41457201]. UCKL1 protein levels are themselves controlled by ubiquitination, being a substrate of the E3 ligase NKLAM [PMID:16709802]. No structural model of the UCKL1 scaffold or the basis of its kinase-independent functions has been characterized in the available corpus.","teleology":[{"year":2006,"claim":"Established that UCKL1 abundance is post-translationally regulated, identifying it as a degradation substrate of the E3 ligase NKLAM and placing it within ubiquitin-dependent control.","evidence":"Yeast two-hybrid screen with reciprocal Co-IP, confocal colocalization, and ubiquitination assay in mammalian cells","pmids":["16709802"],"confidence":"High","gaps":["Functional consequence of NKLAM-mediated UCKL1 degradation not connected to a downstream pathway","No mapping of ubiquitination sites or linkage type"]},{"year":2009,"claim":"Addressed whether UCKL1 contributes to tumor cell survival by showing that its depletion initiates apoptosis, slows the cycle, and increases susceptibility to drug- and NK-induced death.","evidence":"siRNA knockdown in K562 erythroleukemia cells with apoptosis, cell-cycle, and NK cytolysis readouts","pmids":["19653100"],"confidence":"Medium","gaps":["Molecular mechanism of survival not defined","Single cell line, single lab"]},{"year":2016,"claim":"Provided gain-of-function support for the survival role and nominated NF-κB as a downstream effector, while a separate study tied UCKL1 to nucleoside-analog sensitivity via UMP synthesis.","evidence":"Overexpression with NK cytolysis, apoptosis, NF-κB activity assays and in vivo tumor model; chemical screening and knockdown in GBM-initiating cells","pmids":["32083188","27090194"],"confidence":"Medium","gaps":["Mechanistic link between UCKL1 and NF-κB activation not resolved","Enzymatic contribution to UMP synthesis inferred from expression, not directly measured in the GBM context"]},{"year":2022,"claim":"Resolved the long-assumed enzymatic identity by directly reconstituting UCKL1 as a uridine/cytidine kinase with measured kinetic parameters, anchoring its metabolic function.","evidence":"Purified recombinant protein with in vitro kinetic kinase assay, plus siRNA knockdown in an in vivo xenograft model","pmids":["35583288"],"confidence":"High","gaps":["Does not separate metabolic from non-metabolic contributions to tumor growth","No structural basis for substrate selectivity"]},{"year":2023,"claim":"Demonstrated a kinase-independent function by showing UCKL1 stabilizes Nrf2 to induce SLC7A11 and repress ferroptosis, decoupling a survival activity from catalytic activity.","evidence":"RNAi, rescue assays, lipid peroxidation/GSH/metabolomics/RNA-seq, and xenograft validation in colorectal cancer cells","pmids":["37343364"],"confidence":"High","gaps":["Direct mechanism by which UCKL1 stabilizes Nrf2 not defined","Whether ferroptosis axis operates outside colorectal cancer untested"]},{"year":2025,"claim":"Extended the scaffold paradigm beyond cancer, showing a UCKL1-UCK2 complex recruits TRIM21 to degrade Smurf2 and sustain Smad3/TGF-β signaling, driving cardiac fibrosis.","evidence":"Reciprocal Co-IP, western blotting, siRNA and AAV in vivo knockdown, and TGF-β signaling assays in a murine MI model","pmids":["41457201"],"confidence":"Medium","gaps":["Scaffold function lacks structural or reconstitution validation","How UCKL1-UCK2 selects TRIM21 and Smurf2 not defined","Relative contribution of UCKL1 versus UCK2 in the complex unresolved"]},{"year":null,"claim":"How the same protein partitions between its catalytic kinase role and its multiple kinase-independent scaffold/stabilization functions, and what structural features enable each, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of UCKL1 or its complexes","No unified mechanism linking metabolic and non-metabolic activities","Tissue-specific determinants of which function dominates unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[4]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[4]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[6,5]}],"localization":[],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[4]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[1,5]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6]}],"complexes":["UCKL1-UCK2 complex"],"partners":["NKLAM","UCK2","TRIM21"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9NWZ5","full_name":"Uridine-cytidine kinase-like 1","aliases":[],"length_aa":548,"mass_kda":61.1,"function":"May contribute to UTP accumulation needed for blast transformation and proliferation","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9NWZ5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/UCKL1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/UCKL1","total_profiled":1310},"omim":[{"mim_id":"610872","title":"RING FINGER PROTEIN 19B; RNF19B","url":"https://www.omim.org/entry/610872"},{"mim_id":"610866","title":"URIDINE/CYTIDINE KINASE-LIKE 1; UCKL1","url":"https://www.omim.org/entry/610866"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Endoplasmic reticulum","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/UCKL1"},"hgnc":{"alias_symbol":["FLJ20517"],"prev_symbol":["URKL1"]},"alphafold":{"accession":"Q9NWZ5","domains":[{"cath_id":"3.40.50.300","chopping":"96-301","consensus_level":"high","plddt":90.4906,"start":96,"end":301},{"cath_id":"3.40.50.2020","chopping":"308-529","consensus_level":"high","plddt":92.3707,"start":308,"end":529}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NWZ5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NWZ5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NWZ5-F1-predicted_aligned_error_v6.png","plddt_mean":80.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=UCKL1","jax_strain_url":"https://www.jax.org/strain/search?query=UCKL1"},"sequence":{"accession":"Q9NWZ5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NWZ5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NWZ5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NWZ5"}},"corpus_meta":[{"pmid":"16709802","id":"PMC_16709802","title":"NK lytic-associated molecule, involved in NK cytotoxic function, is an E3 ligase.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16709802","citation_count":31,"is_preprint":false},{"pmid":"25491628","id":"PMC_25491628","title":"Both genes and lncRNAs can be used as biomarkers of prostate cancer by using high throughput sequencing data.","date":"2014","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25491628","citation_count":28,"is_preprint":false},{"pmid":"37343364","id":"PMC_37343364","title":"Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer.","date":"2023","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/37343364","citation_count":20,"is_preprint":false},{"pmid":"19653100","id":"PMC_19653100","title":"Downregulation of uridine-cytidine kinase like-1 decreases proliferation and enhances tumor susceptibility to lysis by apoptotic agents and natural killer cells.","date":"2009","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/19653100","citation_count":14,"is_preprint":false},{"pmid":"27090194","id":"PMC_27090194","title":"Chemical Screening Identifies EUrd as a Novel Inhibitor Against Temozolomide-Resistant Glioblastoma-Initiating Cells.","date":"2016","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/27090194","citation_count":12,"is_preprint":false},{"pmid":"35583288","id":"PMC_35583288","title":"Characterization of uridine-cytidine kinase like-1 nucleoside kinase activity and its role in tumor growth.","date":"2022","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/35583288","citation_count":11,"is_preprint":false},{"pmid":"38204987","id":"PMC_38204987","title":"Integrative Analyses of Pyrimidine Salvage Pathway-Related Genes Revealing the Associations Between UPP1 and Tumor Microenvironment.","date":"2024","source":"Journal of inflammation research","url":"https://pubmed.ncbi.nlm.nih.gov/38204987","citation_count":7,"is_preprint":false},{"pmid":"34967537","id":"PMC_34967537","title":"Differential expression patterns of AIP, UCKL1, and PKN1 genes in breast cancer of different molecular subtypes.","date":"2021","source":"Experimental oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34967537","citation_count":4,"is_preprint":false},{"pmid":"38955223","id":"PMC_38955223","title":"Distinct molecular profile of the chick organizer as a stem zone during axial elongation.","date":"2024","source":"Open biology","url":"https://pubmed.ncbi.nlm.nih.gov/38955223","citation_count":3,"is_preprint":false},{"pmid":"32083188","id":"PMC_32083188","title":"Uridine Cytidine Kinase Like-1 Enhances Tumor Cell Proliferation and Mediates Protection from Natural Killer-Mediated Killing.","date":"2016","source":"International journal of immunology and immunotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/32083188","citation_count":3,"is_preprint":false},{"pmid":"30344298","id":"PMC_30344298","title":"Impact of the Uridine⁻Cytidine Kinase Like-1 Protein and IL28B rs12979860 and rs8099917 SNPs on the Development of Hepatocellular Carcinoma in Cirrhotic Chronic Hepatitis C Patients-A Pilot Study.","date":"2018","source":"Medicina (Kaunas, Lithuania)","url":"https://pubmed.ncbi.nlm.nih.gov/30344298","citation_count":3,"is_preprint":false},{"pmid":"35548962","id":"PMC_35548962","title":"DIFFERENTIAL EXPRESSION PATTERN OF AIP, UCKL1, AND PKN1 GENES IN PROSTATE CANCER PATIENTS.","date":"2022","source":"Experimental oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35548962","citation_count":2,"is_preprint":false},{"pmid":"39095742","id":"PMC_39095742","title":"Analysis of different expression RNA binding protein genes in mouse microglia cell from the brains of mice 72 h after subarachnoid hemorrhage or sham operation.","date":"2024","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/39095742","citation_count":1,"is_preprint":false},{"pmid":"40046791","id":"PMC_40046791","title":"Detection of Novel hub-methylated differentially expressed genes in pregnant women with gestational diabetes mellitus via WGCNA of epigenome-wide and transcriptome-wide profiling.","date":"2025","source":"International journal of health sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40046791","citation_count":1,"is_preprint":false},{"pmid":"40837069","id":"PMC_40837069","title":"Genome-Wide Association Study and Rare Variant Association Studies of Strabismus in the All of Us Research Program.","date":"2025","source":"Ophthalmology science","url":"https://pubmed.ncbi.nlm.nih.gov/40837069","citation_count":1,"is_preprint":false},{"pmid":"41457201","id":"PMC_41457201","title":"Uridine-Cytidine Kinase 2 (UCK2)/Uridine-Cytidine Kinase Like 1 (UCKL1) complex exacerbates the differentiation of myocardial fibroblasts via TRIM21/Smurf2/Smad3 pathway after myocardial infarction.","date":"2025","source":"Molecular biomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/41457201","citation_count":0,"is_preprint":false},{"pmid":"40436638","id":"PMC_40436638","title":"Exploring the genetic characteristics of overweight-related osteoarthritis using machine learning.","date":"2025","source":"Computer methods in biomechanics and biomedical engineering","url":"https://pubmed.ncbi.nlm.nih.gov/40436638","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.07.09.25331189","title":"Dissecting the pleiotropic genetic architecture linking telomere biology to chronic respiratory diseases and lung function","date":"2025-07-10","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.09.25331189","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":12712,"output_tokens":1997,"usd":0.034045,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8970,"output_tokens":2600,"usd":0.054925,"stage2_stop_reason":"end_turn"},"total_usd":0.08897,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"UCKL1 (URKL-1) was identified as a substrate of the E3 ubiquitin ligase NKLAM via yeast two-hybrid screening; NKLAM and UCKL1 interact in mammalian cells (confirmed by co-immunoprecipitation and confocal microscopy), and NKLAM-mediated ubiquitination of UCKL1 leads to decreased UCKL1 protein expression.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, confocal microscopy, ubiquitination assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP confirmed in both transfected cells and endogenous protein, plus functional ubiquitination assay, yeast two-hybrid identification; multiple orthogonal methods in a single focused study\",\n      \"pmids\": [\"16709802\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Downregulation of UCKL1 by siRNA in K562 erythroleukemia cells initiated apoptosis, slowed the cell cycle, reduced cell growth, and increased susceptibility to staurosporine-induced apoptosis and NK-mediated cytolysis, establishing a role for UCKL1 in tumor cell survival.\",\n      \"method\": \"RNA interference (siRNA), cell cycle analysis, apoptosis assays, NK cytolysis assay\",\n      \"journal\": \"Apoptosis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KD with defined cellular phenotype using multiple readouts (apoptosis, cell cycle, NK killing), single lab\",\n      \"pmids\": [\"19653100\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"UCKL1 over-expression in tumor cells protects against NK-mediated killing, spontaneous and drug-induced apoptosis, and increases tumor cell proliferation; NF-κB activity is elevated in UCKL1-overexpressing cells, suggesting NF-κB as a downstream mechanism of UCKL1-mediated survival.\",\n      \"method\": \"Overexpression transfection, NK cytolysis assay, apoptosis assay, NF-κB reporter/activity assay, in vivo tumor model\",\n      \"journal\": \"International journal of immunology and immunotherapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function with multiple phenotypic readouts and in vivo validation, NF-κB activity measured, single lab\",\n      \"pmids\": [\"32083188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"UCKL1 expression level in glioblastoma-initiating cells correlates with sensitivity to the nucleoside analog EUrd; UCKL1 positively regulates UMP synthesis, and increased UCKL1 expression together with decreased NT5C3 expression underlies the cytotoxic effect of EUrd on temozolomide-resistant GBM-initiating cells.\",\n      \"method\": \"Chemical screening, siRNA knockdown, cell viability assays, gene expression analysis\",\n      \"journal\": \"Stem cells\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — pharmacological/expression correlation with partial mechanistic follow-up; enzyme activity in this context inferred, not directly measured\",\n      \"pmids\": [\"27090194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Purified recombinant UCKL1 phosphorylates uridine and cytidine using ATP as phosphate donor in vitro, with catalytic efficiencies (kcat/KM) of 1.2×10⁴ s⁻¹M⁻¹ for uridine and 0.7×10⁴ s⁻¹M⁻¹ for cytidine, establishing UCKL1 as a bona fide pyrimidine kinase. siRNA-mediated knockdown of UCKL1 in vivo reduced primary tumor growth and metastasis.\",\n      \"method\": \"Protein purification, in vitro kinase assay (kinetic characterization), siRNA knockdown, in vivo xenograft model\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro enzymatic reconstitution with kinetic parameters, complemented by in vivo loss-of-function; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"35583288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"UCKL1 represses ferroptosis in colorectal cancer cells through a non-canonical, kinase-activity-independent mechanism: UCKL1 stabilizes Nrf2 protein, which in turn promotes expression of SLC7A11 (a ferroptosis repressor). UCKL1 knockdown enhanced lipid peroxidation and sensitized cells to GPX4 inhibitors in vitro and in vivo.\",\n      \"method\": \"RNA interference, GSH/GSSG assay, NADP+ assay, ROS and lipid peroxidation assays, metabolomics, RNA sequencing, western blotting, rescue assays, xenograft mouse model\",\n      \"journal\": \"EBioMedicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal biochemical assays, rescue experiments, and in vivo validation establishing the UCKL1-Nrf2-SLC7A11 axis; single lab but comprehensive approach\",\n      \"pmids\": [\"37343364\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"UCKL1 and UCK2 physically assemble into a protein complex that acts as a molecular scaffold (independent of enzymatic/metabolic function) and recruits the E3 ubiquitin ligase TRIM21 to ubiquitinate and degrade Smurf2, thereby sustaining Smad3 phosphorylation and amplifying TGF-β fibrogenic signaling in cardiac fibroblasts. Combined genetic silencing of UCK2 and UCKL1 reduced myofibroblast differentiation and preserved cardiac function in a murine MI model.\",\n      \"method\": \"Co-immunoprecipitation (complex formation), western blotting, siRNA knockdown, AAV-mediated in vivo knockdown, murine MI model, TGF-β signaling assays\",\n      \"journal\": \"Molecular biomedicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP for complex, in vivo functional validation, multiple mechanistic readouts; single lab, no structural/reconstitution validation of scaffold function\",\n      \"pmids\": [\"41457201\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"UCKL1 is a pyrimidine salvage pathway enzyme (uridine/cytidine kinase) that also functions as a molecular scaffold: it is ubiquitinated and degraded by the E3 ligase NKLAM, protects tumor cells from apoptosis and NK-mediated killing partly via NF-κB, represses ferroptosis through a UCKL1-Nrf2-SLC7A11 axis independent of its kinase activity, and forms a complex with UCK2 that recruits TRIM21 to degrade Smurf2 and sustain Smad3/TGF-β fibrogenic signaling in cardiac fibroblasts.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"UCKL1 is a pyrimidine salvage enzyme that doubles as a pro-survival and pro-fibrotic molecular scaffold, coupling nucleotide metabolism to cell-fate signaling in tumor and fibroblast contexts [#4, #5]. As an enzyme, purified recombinant UCKL1 phosphorylates uridine and cytidine using ATP, establishing it as a bona fide uridine/cytidine kinase that drives UMP synthesis [#4, #3]. Independent of this catalytic activity, UCKL1 promotes tumor cell survival: its loss triggers apoptosis, slows the cell cycle, and sensitizes cells to staurosporine and NK-mediated cytolysis, while its overexpression confers resistance to killing and elevates NF-\\u03baB activity [#1, #2]. A non-canonical, kinase-independent axis explains part of this survival role, in which UCKL1 stabilizes Nrf2 to induce the ferroptosis repressor SLC7A11, so that UCKL1 loss enhances lipid peroxidation and sensitizes cells to GPX4 inhibitors [#5]. UCKL1 also assembles with UCK2 into a scaffold that recruits the E3 ligase TRIM21 to ubiquitinate and degrade Smurf2, thereby sustaining Smad3 phosphorylation and amplifying TGF-\\u03b2 fibrogenic signaling in cardiac fibroblasts [#6]. UCKL1 protein levels are themselves controlled by ubiquitination, being a substrate of the E3 ligase NKLAM [#0]. No structural model of the UCKL1 scaffold or the basis of its kinase-independent functions has been characterized in the available corpus.\",\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"Established that UCKL1 abundance is post-translationally regulated, identifying it as a degradation substrate of the E3 ligase NKLAM and placing it within ubiquitin-dependent control.\",\n      \"evidence\": \"Yeast two-hybrid screen with reciprocal Co-IP, confocal colocalization, and ubiquitination assay in mammalian cells\",\n      \"pmids\": [\"16709802\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of NKLAM-mediated UCKL1 degradation not connected to a downstream pathway\", \"No mapping of ubiquitination sites or linkage type\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Addressed whether UCKL1 contributes to tumor cell survival by showing that its depletion initiates apoptosis, slows the cycle, and increases susceptibility to drug- and NK-induced death.\",\n      \"evidence\": \"siRNA knockdown in K562 erythroleukemia cells with apoptosis, cell-cycle, and NK cytolysis readouts\",\n      \"pmids\": [\"19653100\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism of survival not defined\", \"Single cell line, single lab\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Provided gain-of-function support for the survival role and nominated NF-\\u03baB as a downstream effector, while a separate study tied UCKL1 to nucleoside-analog sensitivity via UMP synthesis.\",\n      \"evidence\": \"Overexpression with NK cytolysis, apoptosis, NF-\\u03baB activity assays and in vivo tumor model; chemical screening and knockdown in GBM-initiating cells\",\n      \"pmids\": [\"32083188\", \"27090194\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic link between UCKL1 and NF-\\u03baB activation not resolved\", \"Enzymatic contribution to UMP synthesis inferred from expression, not directly measured in the GBM context\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Resolved the long-assumed enzymatic identity by directly reconstituting UCKL1 as a uridine/cytidine kinase with measured kinetic parameters, anchoring its metabolic function.\",\n      \"evidence\": \"Purified recombinant protein with in vitro kinetic kinase assay, plus siRNA knockdown in an in vivo xenograft model\",\n      \"pmids\": [\"35583288\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not separate metabolic from non-metabolic contributions to tumor growth\", \"No structural basis for substrate selectivity\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstrated a kinase-independent function by showing UCKL1 stabilizes Nrf2 to induce SLC7A11 and repress ferroptosis, decoupling a survival activity from catalytic activity.\",\n      \"evidence\": \"RNAi, rescue assays, lipid peroxidation/GSH/metabolomics/RNA-seq, and xenograft validation in colorectal cancer cells\",\n      \"pmids\": [\"37343364\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct mechanism by which UCKL1 stabilizes Nrf2 not defined\", \"Whether ferroptosis axis operates outside colorectal cancer untested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended the scaffold paradigm beyond cancer, showing a UCKL1-UCK2 complex recruits TRIM21 to degrade Smurf2 and sustain Smad3/TGF-\\u03b2 signaling, driving cardiac fibrosis.\",\n      \"evidence\": \"Reciprocal Co-IP, western blotting, siRNA and AAV in vivo knockdown, and TGF-\\u03b2 signaling assays in a murine MI model\",\n      \"pmids\": [\"41457201\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Scaffold function lacks structural or reconstitution validation\", \"How UCKL1-UCK2 selects TRIM21 and Smurf2 not defined\", \"Relative contribution of UCKL1 versus UCK2 in the complex unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the same protein partitions between its catalytic kinase role and its multiple kinase-independent scaffold/stabilization functions, and what structural features enable each, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of UCKL1 or its complexes\", \"No unified mechanism linking metabolic and non-metabolic activities\", \"Tissue-specific determinants of which function dominates unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [6, 5]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [1, 5]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"complexes\": [\"UCKL1-UCK2 complex\"],\n    \"partners\": [\"NKLAM\", \"UCK2\", \"TRIM21\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":6,"faith_pct":83.33333333333333}}